Marfan Abl-alrazaq Mohammad, Ashraf Olabi, Raghda Lahdo



Objective: Despite the using of some biological and clinical criteria for definition of Polycystic ovarian syndrome, such as hyperandrogenism and menstrual dysfunction. However, the complex mechanism of this syndrome is still of interest to researchers, and began to investigate new parameters intervene in the pathogenesis of this disease, including leptin and C-reactive protein (CRP). However, the role of these parameters are still not clear and under controversy. This study, aimed to investigate the relationship between serum leptin levels with C-reactive protein in patients diagnosed with polycystic ovarian syndrome attending Aleppo gynecology university hospital.

Methods: The study includes 46 patients and 25 healthy control subjects with the same range of age- and body mass index. Related parameters were measured for both groups: serum glucose, leptin, insulin and C-reactive protein levels, and homeostasis model assessment of insulin resistance (HOMA-IR).

Results: Serum leptin levels were significantly correlated with C-reactive protein only in Polycystic ovarian syndrome group (p<0.05). The levels of C-reactive protein and leptin were significantly higher in the Polycystic ovarian syndrome group in comparison with the control group (p<0.05). There were a correlation between leptin with C-reactive protein only in patients with insulin resistance group (p > 0.05), and there was a correlation between C-reactive protein and HOMA-IR only in polycystic ovarian syndrome group (p>   0.001), but not in control group.

Conclusion: Increased leptin, C-reactive protein levels in polycystic ovarian syndrome patients is independently associated with insulin resistance and make these parameters more important to take them in consideration.

 Keywords: CRP, HOMA-IR, Leptin, PCOS.


| PDF |


Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997; 18: 774–800. doi: 10.1210/edrv.18.6.0318. PubMed PMID: 9408743.

Franks S. Polycystic ovary syndrome. New England Journal of Medicine 1995; 333: 853–861. doi: 10.1056/NEJM199509283331307. PubMed PMID: 7651477.

Diamanti-Kandarakis E, Argyrakopoulou G, Economou F. Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS). J Steroid Biochem Mol Biol 2008; 109: 242-6. doi: 10.1016/j.jsbmb.2008.03.014. PubMed PMID: 18440223.

Muscari A, Antonelli S, Bianchi G, Cavrini G, Dapporto S, Ligabue A et al. Serum C3 is a stronger inflammatory marker of insulin resistance than C reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population. Diabetes Care 2007; 30(9): 2362-2368. doi: 10.2337/dc07-0637. PubMed PMID: 17595349.

Legro RS, Gnatuk CL, Kunselman AR, Andrea D. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2005; 90: 3236-3242. doi: 10.1210/jc.2004-1843. PubMed PMID: 15797965.

Chang JR, Nakamura RM, Judd HL, Kaplan SA. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 1983; 57: 356–359. doi: 10.1210/jcem-57-2-356. PubMed PMID: 6223044.

Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 2006; 119(4): 1–6. doi: 10.1016/j.amjmed.2005.10.059. PubMed PMID: 16564785.

Ryu SY, Kim KS, Park J, Kang MG, Han MA. The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults. J Prev Med Public Health 2008; 41: 413-418. doi: 10.3961/jpmph.2008.41.6.413. PubMed PMID: 19037171.

Legro RS. Diabetes prevalence and risk factors in polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001; 28(1):99-109. doi: 10.1016/S0889-8545(05)70188-1. PubMed PMID: 11293007.

Bates S. H, Myers M. G. Jr. The role of leptin receptor signaling in feeding and neuroendocrine function. Trends Endocrinol. Metab 2003;14: 447–452. doi: 10.1016/j.tem.2003.10.003. PubMed PMID: 14643059.

Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398–401. doi:10.1038/32911 . PubMed PMID: 9537324.

Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 1455-1462. doi: 10.2337/diab.45.11.1455 . PubMed PMID: 8866547

Kowalska I, Kinalski M, Straczkowski M, Wolczyski S, Kinalska I. Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome. Eur J Endocrinol 2001;144: 509-515. doi: 10.1530/eje.0.1440509 . PubMed PMID: 11331217.

Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M, et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg Cohort Study, 1984–1998. Archives of Internal Medicine 2003; 163: 93–99. doi: 10.1001/archinte.163.1.93. PubMed PMID: 12523922

Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 2001; 286: 327–334. doi:10.1001/jama.286.3.327. PubMed PMID: 11466099.

Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in theWest of Scotland Coronary Prevention Study. Diabetes 2002; 51: 1596–1600. doi: 10.2337/diabetes.51.5.1596. PubMed PMID: 11978661.

Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 2001; 86: 2453–2455. doi: 10.1210/jcem.86.6.7580. PubMed PMID: 11397838.

Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003 52 942–947. doi: 10.2337/diabetes.52.4.942. PubMed PMID: 12663465.

Festa A, D’Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42–47. doi: 10.1161/01.CIR.102.1.42. PubMed PMID: 10880413.

Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, et al. Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. Journal of Clinical Endocrinology and Metabolism 2001; 86: 1154–1159. doi: 10.1210/jcem.86.3.7305. PubMed PMID: 11238501.

Sampson M., Kong C., Patel A., Unwin R.,Jacobs H.S. Ambulatory blood pressure profi les and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. J.Clin. Endocrinol 1996; 45: 623–629. doi: 10.1046/j.1365-2265.1996.00863.x. PubMed PMID: 8977761.

Boulman N., Levy Y., Leiba R., Shachar S., Linn R., Zinder O., et al. Increased C-reactive protein levels in the polycystic ovary syndrome: A marker of cardiovascular disease. J. Clin. Endocrinol. Metab 2004; 89(5): 2160 - 2165. doi: 10.1210/jc.2003-03109 . PubMed PMID: 15126536.

Yang S, Li Q, Song Y, Tian B, Cheng Q, Qing H. Serum complement C3 has a stronger association with insulin resistance than high-sensitivity C-reactive protein in women with polycystic ovary syndrome. Fertil Steril 2011; 95(5): 1749-1753. doi: 10.1016/j.fertnstert.2011.01.136. PubMed PMID: 21316661.

Macchi M, Pieroni L, Bruckert E. Systemic low grade inflammation is related to both circulating and adipose tissue TNF alpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004; 28: 993–997. doi:10.1038/sj.ijo.0802718. PubMed PMID: 15211360.

Steensberg A, Fischer CP, Sacchetti M, Keller C, Osada T, Schjerling P, et al. Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. Journal of Physiology 2003; 548: 631–638. doi: 10.1113/jphysiol.2002.032938. PubMed PMID: 12640021.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81(1): 19–25. doi: 10.106/j.fertnstert.2003.10.004. PubMed PMID: 14711538.

Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutrition &Metabolism 2010;7(26): 1-8. doi: 10.1186/1743-7075-7-26. PubMed PMID: 2857836.

Qu HQ1, Li Q, Rentfro AR, Fisher-Hoch SP, McCormick JB. The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. PLoS One 2011; 6(6): 21-41. doi: 10.1371/journal.pone.0021041. PubMed PMID: 21695082.

Mohammad M, Olabi A, Lahdo R. Investigating the Relationship between Serum Leptin levels and Insulin Resistance in Poly Cystic Ovary Syndrome (PCOS) Patients. IJASR 2016;4(1):56-65.

Chen K, Li F, Li J, Cai H, Strom S, Bisello A, et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 2006; 12(4): 425-32. doi:10.1038/nm1372. PubMed PMID: 16582918.

Asmathulla S, Rupa Vnai K, Kripa S, Rajarajeswari R. Insulin resistance and its relation to inflammatory status and serum lipids among young women with PCOS. Int Repord Contracept Obstet Gynecol 2013; 2(3): 325-329. doi: 10.5455/2320-1770.ijrcog20130913.

Calvar CE, Intebi AD, Bengolea SV, Hermes R, Spinedi E. Leptin in patients with polycystic ovary syndrome. Direct correlation with insulin resistance. Medicina 2003; 63(6): 704-10. PubMed PMID: 14719312.

Morreale HFE, Ramírez ML, González F. CIRCULATING INFLAMMATORY MARKERS IN POLYCYSTIC OVARY SYNDROME: A SYSTEMATIC REVIEW AND METAANALYSIS. Fertil Steril 2011; 95(3): 1048–58. doi: 10.1016/j.fertnstert.2010.11.036. PubMed PMID: 3079565.

Xita N, Papassotiriou L, Georgiou L, Vounatsou M, Margeli A, Tsatsoulis A. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers. Elsevier Inc 2007; 56(6): 766-771. doi: 10.1016/j.metabol.2007.01.008 . PubMed PMID: 17512308.

Nakanishi N, Shiraishi T, Wada M. Association between C-reactive protein and insulin resistance in a Japanese population, the Minoh Study. Intern Med 2005; 44: 542-547. doi: 10.2169/internalmedicine.44.542. PubMed PMID: 16020877.

Mo¨hlig M, Spranger J, Osterhoff M, Ristow M, Pfeiffer AF, Schill T, et al. The polycystic ovary syndrome per se is not associated with increased chronic inflammation. European Journal of Endocrinology 2004; 150: 525–532. doi: 10.1530/eje.0.1500525. PubMed PMID: 15080783.

Dehdashtihaghighat S, Mehdizadehkashi A, Arbabi A, Pishgahroudsari M, Chaichian S. Assessment of C - reactive protein and C3 as Inflammatory Markers of Insulin Resistance in Women with Polycystic Ovary Syndrome: A Case-Control Study. J Reprod Infertil 2013; 14(4): 197-201. PubMed PMID: 24551574; PMCID: PMC3911815.

Festa A., D’Agostino R.J., Howard G., Mykkanen L., Tracy R.P., Haff ner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome. The Insulin Resistance Atherosclerosis Study (IRAS) 2000; 102: 42–47. doi: 10.1161/01.CIR.102.1.42 . PubMed PMID: 10880413.

Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454. doi: 10.1056/NEJM199902113400607. PubMed PMID: 9971870.

Velija-Ašimi Z. C - reactive protein in Obese PCOS Women and the Effect of Metformin Therapy. BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES 2007; 7 (1): 90-93. PubMed PMID: 17489777.

About this article





Additional Links

Manuscript Submission


Innovare Journal of Medical Sciences
Vol 4 Issue 3 (June-July) Page: 10-13

Online ISSN


Authors & Affiliations

Marfan Abl-alrazaq Mohammad
Aleppo university
Syrian Arab Republic

Ashraf Olabi
Faculty of medicine
Syrian Arab Republic

Raghda Lahdo
faculty of pharmacy/ University of Aleppo
Syrian Arab Republic